B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.

about

Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.Vaccinia virus vaccines: past, present and future.Vaccinia virus A35R inhibits MHC class II antigen presentation.

P2860

Q35826728-305B0595-21AB-4C05-B528-56F14F0FA2D8 Q37343595-5B211D75-DDAF-47C2-B32C-38F199D2BA8A Q39390434-852DE84B-637D-4221-84F8-561CD3306151

P2860

B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.

Item

http://www.wikidata.org/entity/Q36103012

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

B5-deficient vaccinia virus as ...... en in vaccinia immune animals.

@ast

B5-deficient vaccinia virus as ...... en in vaccinia immune animals.

@en

type

Item

label

B5-deficient vaccinia virus as ...... en in vaccinia immune animals.

@ast

B5-deficient vaccinia virus as ...... en in vaccinia immune animals.

@en

prefLabel

B5-deficient vaccinia virus as ...... en in vaccinia immune animals.

@ast

B5-deficient vaccinia virus as ...... en in vaccinia immune animals.

@en

P1476

B5-deficient vaccinia virus as ...... en in vaccinia immune animals.

@en

P2093

Heesun Kwak

http://www.w3.org/2001/XMLSchema#string

Kendra M Viner

http://www.w3.org/2001/XMLSchema#string

Natasha Girgis

http://www.w3.org/2001/XMLSchema#string

Stuart N Isaacs

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a preventive vaccine for Ebola virus infection in primates

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.

Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.

Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.

Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.

Intralesional vaccinia/GM-CSF recombinant virus in the treatment of metastatic melanoma.

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.

Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.

P304

356-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2006.11.020

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6611296

http://www.w3.org/2001/XMLSchema#string

P698

17188733

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

2048764

http://www.w3.org/2001/XMLSchema#string

B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.

about

P2860

P2860

B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932